Latuda and Aricept drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Latuda (lurasidone hydrochloride) and Aricept (donepezil hydrochloride). Common drug interactions include fall among females and bone density decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Latuda and Aricept. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Latuda?

Latuda has active ingredients of lurasidone hydrochloride. It is often used in bipolar disorder. eHealthMe is studying from 21,543 Latuda users. Check the latest studies of Latuda.

What is Aricept?

Aricept has active ingredients of donepezil hydrochloride. It is often used in alzheimer's disease. eHealthMe is studying from 24,756 Aricept users. Check the latest studies of Aricept.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 04, 2026

24 people who take Latuda and Aricept together, and have interactions are studied.

Latuda and Aricept drug interactions.

What are the common drug interactions of Latuda and Aricept, by gender? *:

female:

  1. Fall
  2. Infection
  3. Fatigue (feeling of tiredness)
  4. Muscular weakness (muscle weakness)
  5. Pain in extremity
  6. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  7. Balance disorder
  8. Blindness
  9. Chest pain
  10. Disorientation (disability in which the senses of time, direction, and recognition of people and places)

male:

  1. Bone density decreased
  2. Bone loss
  3. Chronic kidney disease
  4. Emotional disorder
  5. Fracture
  6. Granulocytopenia (lack of granulocyte)
  7. Knee arthroplasty
  8. Leukopenia (less number of white blood cells in blood)
  9. Osteonecrosis (death of bone)
  10. Tooth loss

What are the common drug interactions of Latuda and Aricept, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Bone density decreased
  2. Bone loss
  3. Chronic kidney disease
  4. Emotional disorder
  5. Fracture
  6. Knee arthroplasty
  7. Osteonecrosis (death of bone)
  8. Tooth loss

50-59:

n/a

60+:

  1. Fall
  2. Fatigue (feeling of tiredness)
  3. Abulia (lack of will or initiative)
  4. Communication disorder (speech and language disorder)
  5. Hydrocephalus (water on the brain)
  6. Personality disorder
  7. Psychotic disorder
  8. Abdominal neoplasm (cancer of the stomach)
  9. Agitation (state of anxiety or nervous excitement)
  10. Akathisia (a movement disorder characterized by a feeling of inner restlessness)

What are the existing conditions these people have? *

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 7 people, 29.17%
  2. Tardive Dyskinesia (a disorder that involves involuntary movements): 5 people, 20.83%
  3. Depression: 5 people, 20.83%
  4. Stress And Anxiety: 4 people, 16.67%
  5. Memory Loss: 3 people, 12.50%
  6. Insomnia (sleeplessness): 3 people, 12.50%
  7. High Blood Pressure: 3 people, 12.50%
  8. Psychotic Disorder: 2 people, 8.33%
  9. Pollakiuria (abnormally frequent passage of relatively small quantities or urine): 2 people, 8.33%
  10. Pain: 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Latuda and Aricept?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Latuda and Aricept:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Latuda:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Aricept:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Latuda and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Aricept and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on lurasidone hydrochloride and donepezil hydrochloride (the active ingredients of Latuda and Aricept, respectively), and Latuda and Aricept (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: